ATE525111T1 - 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6- - Google Patents

2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6-

Info

Publication number
ATE525111T1
ATE525111T1 AT04728020T AT04728020T ATE525111T1 AT E525111 T1 ATE525111 T1 AT E525111T1 AT 04728020 T AT04728020 T AT 04728020T AT 04728020 T AT04728020 T AT 04728020T AT E525111 T1 ATE525111 T1 AT E525111T1
Authority
AT
Austria
Prior art keywords
amine
corneal
post
indazolyluquinazoline
indazole
Prior art date
Application number
AT04728020T
Other languages
English (en)
Inventor
Yoshiko Takayama
Yoshikuni Nakamura
Jun Inoue
Mitsuyoshi Azuma
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE525111T1 publication Critical patent/ATE525111T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22054—Calpain-3 (3.4.22.54), i.e. calpain p94

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04728020T 2003-04-18 2004-04-16 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6- ATE525111T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003114819 2003-04-18
JP2003273177 2003-07-11
PCT/JP2004/005456 WO2004091662A1 (ja) 2003-04-18 2004-04-16 角膜知覚回復剤

Publications (1)

Publication Number Publication Date
ATE525111T1 true ATE525111T1 (de) 2011-10-15

Family

ID=33302244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04728020T ATE525111T1 (de) 2003-04-18 2004-04-16 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6-

Country Status (9)

Country Link
US (1) US20070093513A1 (de)
EP (1) EP1616577B1 (de)
JP (1) JP4566130B2 (de)
KR (1) KR101076638B1 (de)
CN (1) CN1777445B (de)
AT (1) ATE525111T1 (de)
ES (1) ES2370245T3 (de)
PL (1) PL1616577T3 (de)
WO (1) WO2004091662A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009028631A1 (ja) * 2007-08-29 2009-03-05 Senju Pharmaceutical Co., Ltd. 角膜内皮細胞接着促進剤
US20090325959A1 (en) * 2008-06-26 2009-12-31 Vittitow Jason L Method for treating ophthalmic diseases using rho kinase inhibitor compounds
US10842669B2 (en) * 2008-11-13 2020-11-24 Gholam A. Peyman Ophthalmic drug delivery method
RU2448654C1 (ru) * 2010-12-14 2012-04-27 Государственное образовательное учреждение высшего профессионального образования Смоленская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию Способ диагностики чувствительности роговицы глаза
RU2494735C1 (ru) * 2012-06-21 2013-10-10 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения язвы роговицы
EP3308784A4 (de) * 2015-06-09 2019-02-06 Senju Pharmaceutical Co., Ltd. Therapeutikum für neurotrophe keratopathie

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4295259A (en) * 1978-10-13 1981-10-20 Canron Corp. Method of filling spike holes in railway ties
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
US4661532A (en) * 1985-06-25 1987-04-28 H. B. Fuller Company Coal tar containing foaming urethane composition and a method for repairing defects in structural components
US4738878A (en) * 1987-03-30 1988-04-19 Osmose Wood Preserving, Inc. In situ preservative treatment of railroad tie
BR9711154A (pt) * 1996-08-12 1999-08-17 Yoshitomi Pharmaceutical Agente farmac-utico contendo inibidor cinase rho
US5952072A (en) * 1997-06-09 1999-09-14 Willamette Valley Company Method for restoring used railroad ties and the restored railroad ties formed thereby
US6455605B1 (en) * 1997-09-10 2002-09-24 H. B. Fuller Licensing & Financing Inc. Foamable composition exhibiting instant thixotropic gelling
US20080233098A1 (en) * 1997-10-31 2008-09-25 Mckerracher Lisa RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
JP3616867B2 (ja) * 1998-05-25 2005-02-02 参天製薬株式会社 新規ビニルベンゼン誘導体
WO1999061403A1 (en) * 1998-05-25 1999-12-02 Santen Pharmaceutical Co., Ltd. Novel vinylbenzene derivatives
US7169783B2 (en) * 1998-11-02 2007-01-30 Universite De Montreal (+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
WO2001068607A1 (en) * 2000-03-16 2001-09-20 Mitsubishi Pharma Corporation Amide compounds and use thereof
PE20020958A1 (es) * 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
US7109208B2 (en) * 2001-04-11 2006-09-19 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents
WO2002100833A1 (en) * 2001-06-12 2002-12-19 Sumitomo Pharmaceuticals Company, Limited Rho KINASE INHIBITORS
BR0212151A (pt) * 2001-08-29 2004-08-24 Alcon Inc Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumas
JP2003073357A (ja) * 2001-09-03 2003-03-12 Mitsubishi Pharma Corp アミド化合物を含有するＲｈｏキナーゼ阻害剤
US6821631B2 (en) * 2001-10-29 2004-11-23 Wood Treatment Products, Inc. Method and composition for treating substrates
US7195823B2 (en) * 2002-06-20 2007-03-27 Mississippi State University Delivery system for supplemental wood preservative and/or metal corrosion inhibition treatment
CA2420777A1 (en) * 2003-03-04 2004-09-04 H.B. Fuller Licensing & Financing, Inc. Polyurethane composition containing a property-enhancing agent
US7485654B2 (en) * 2004-06-03 2009-02-03 Senju Pharmaceutical Co., Ltd. Corneal perception recovery drug containing amide compound
US20070042161A1 (en) * 2005-08-16 2007-02-22 Gibbs Group Holdings, Inc. Decay resistant wooden railroad crosstie and method for making same
US7632557B2 (en) * 2006-05-17 2009-12-15 Williamette Valley Company Method for restoring used railroad ties and the restored railroad ties formed thereby

Also Published As

Publication number Publication date
PL1616577T3 (pl) 2012-02-29
CN1777445A (zh) 2006-05-24
CN1777445B (zh) 2010-04-14
KR101076638B1 (ko) 2011-10-27
EP1616577A4 (de) 2010-03-10
EP1616577B1 (de) 2011-09-21
KR20050111645A (ko) 2005-11-25
EP1616577A1 (de) 2006-01-18
ES2370245T3 (es) 2011-12-13
US20070093513A1 (en) 2007-04-26
JPWO2004091662A1 (ja) 2006-07-06
WO2004091662A1 (ja) 2004-10-28
JP4566130B2 (ja) 2010-10-20

Similar Documents

Publication Publication Date Title
SE0201976D0 (sv) Novel compounds
DE60237725D1 (de) Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
SE0201980D0 (sv) Novel compounds
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
DK1680507T3 (da) Bakterieekspression af proteaseinhibitorer og varianter deraf
EP4217352A4 (de) Substituierte n-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamidanaloga als modulatoren des cereblonproteins
DE60323155D1 (de) Von transthyretin und zur hemmung von transthyretin-fehlfaltung
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
ATE361067T1 (de) Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen
ATE490771T1 (de) Therapeutisches mittel für keratokonjunktive erkrankungen
TW200736255A (en) 5-(Substituted)-pyrazolopiperidines
EP1689766A4 (de) Expression von proteaseinhibitoren und varianten davon in filamentösen pilzen
SE0201977D0 (sv) Novel compounds
ATE525111T1 (de) 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6-
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
DOP2002000451A (es) Nuevas ciclohexilsulfonas (agentes terapéuticos)
DE602005010421D1 (de) Neue Cysteine Protease Hemmers und ihre therapeutische Anwendungen
SE0203712D0 (sv) Novel compounds
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
EA200700406A1 (ru) Производные хиназолина , применяемые для лечения поражений периферических артерий и в качестве ингибиторов фосфодиэстеразы
ATE300538T1 (de) Das hydrochloridsalz des 5(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dio s
ATE330938T1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties